Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Retatrutide is an investigational triple-agonist peptide designed to activate: GLP-1 (Glucagon-Like Peptide-1) receptors GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors Glucagon receptors By targeting all three pathways, retatrutide addresses appetite regulation, insulin resistance, energy expenditure, and fat metabolism together rather than focusing on appetite suppression alone
Enteroendocrine cells express functional Toll-like receptors
MC3/4R activation reduces food intake in rodent models, though the effect tolerates with repeated dosing
Through education and awareness, patients can feel more empowered to take an active role in their treatment, leading to better health outcomes and improved quality of life
US$ 28.84
US$ 24.61
US$ 24.97
US$ 22.95
US$ 27.29
US$ 20.45
US$ 24.19
US$ 28.93
US$ 27.59
US$ 22.46
